CS
Catherine Schulte Baird Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
27
Avg Return
Past Year
Past Year
0.72%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
80.8%
Neutral
19.2%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Health Information Services
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $28 |
32%
upside
| 2 | -4% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $82 |
59%
upside
| 2 | -26% |
0
%
| 20 Feb ‘26 1 month ago |
|
|
|
Outperform
Initiated
| $59 |
6%
upside
| 1 | -2.7% |
0
%
| 17 Feb ‘26 2 months ago |
|
|
|
Outperform
Initiated
| $120 |
33%
upside
| 1 | -17% |
0
%
| 17 Feb ‘26 2 months ago |
|
|
|
Outperform
Maintained
| $165 |
35%
upside
| 3 | +3.8% |
0
%
| 25 Nov ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $88 |
16%
downside
| 2 | +48% |
0
%
| 4 Nov ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $17 |
100%
upside
| 4 | -5.9% |
0
%
| 24 Oct ‘25 5 months ago |
|
|
|
Neutral
Maintained
| $1,230 |
8%
downside
| 3 | – |
–
| 4 Aug ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $567 |
8%
upside
| 3 | +3.1% |
0
%
| 24 Jul ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $229 |
18%
upside
| 4 | +0.14% |
0
%
| 23 Jul ‘25 9 months ago |
|
|
|
Neutral
Maintained
| $2 |
41%
downside
| 1 | -60% |
–
| 13 May ‘25 11 months ago |
|
|
|
Neutral
Maintained
| $43 |
4%
upside
| 1 | – |
–
| 21 Apr ‘25 1 year ago |
|